Robert Andrade, CHIEF FINANCIAL OFFICER at FENNEC PHARMACEUTICALS INC. (FENC), sold 27,950 shares at $10.90 ($305K) on 2024-03-26, disclosed to the SEC on 2024-03-27.
Open-market sale of $305k FENC by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.90 | 13,975 | $152K | 50.0% |
| 2 | $10.90 | 13,975 | $152K | 50.0% |
| Total | $10.90 avg | 27,950 | $305K | 100% |
| Filing → |
| FENC | SELL | 2024-01-05 | $316K | — | Filing → |
| FENC | SELL | 2023-06-30 | $223K | — | Filing → |
| FENC | SELL | 2022-12-30 | $211K | — | Filing → |